Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Medicinal Chemistry
|
November 5, 2011
New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis
J M Beierlein, A C Anderson
Nature
|
November 26, 1999
Two networks of electrically coupled inhibitory neurons in neocortex
J R Gibson, M Beierlein, B W Connors
Journal of Neurophysiology
|
October 1, 1995
Inhibitory control of excitable dendrites in neocortex
H G Kim, M Beierlein, B W Connors
Nature Neuroscience
|
August 31, 2000
A network of electrically coupled interneurons drives synchronized inhibition in neocortex
M Beierlein, J R Gibson, B W Connors
Journal of Medicinal Chemistry
|
October 2, 2010
Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships
Jennifer M Beierlein, Nanda G Karri, Amy C Anderson
Molecular Therapy. Nucleic Acids
|
December 17, 2017
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
Jennifer M Beierlein, Laura M McNamee, Fred D Ledley
Clinical Therapeutics
|
August 6, 2015
Patterns of Innovation in Alzheimer's Disease Drug Development: A Strategic Assessment Based on Technological Maturity
Jennifer M Beierlein, Laura M McNamee, Michael J Walsh, et al.
Biochemistry
|
March 28, 2009
The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors
Jennifer M Beierlein, Lalit Deshmukh, Kathleen M Frey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 23, 1999
Alternative splicing of a short cassette exon in alpha1B generates functionally distinct N-type calcium channels in central and peripheral neurons
Z Lin, Y Lin, S Schorge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2018
Contribution of NIH funding to new drug approvals 2010-2016
Ekaterina Galkina Cleary, Jennifer M Beierlein, Navleen Surjit Khanuja, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Medicinal Chemistry
|
November 5, 2011
New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis
J M Beierlein, A C Anderson
Nature
|
November 26, 1999
Two networks of electrically coupled inhibitory neurons in neocortex
J R Gibson, M Beierlein, B W Connors
Journal of Neurophysiology
|
October 1, 1995
Inhibitory control of excitable dendrites in neocortex
H G Kim, M Beierlein, B W Connors
Nature Neuroscience
|
August 31, 2000
A network of electrically coupled interneurons drives synchronized inhibition in neocortex
M Beierlein, J R Gibson, B W Connors
Journal of Medicinal Chemistry
|
October 2, 2010
Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships
Jennifer M Beierlein, Nanda G Karri, Amy C Anderson
Molecular Therapy. Nucleic Acids
|
December 17, 2017
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
Jennifer M Beierlein, Laura M McNamee, Fred D Ledley
Clinical Therapeutics
|
August 6, 2015
Patterns of Innovation in Alzheimer's Disease Drug Development: A Strategic Assessment Based on Technological Maturity
Jennifer M Beierlein, Laura M McNamee, Michael J Walsh, et al.
Biochemistry
|
March 28, 2009
The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors
Jennifer M Beierlein, Lalit Deshmukh, Kathleen M Frey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 23, 1999
Alternative splicing of a short cassette exon in alpha1B generates functionally distinct N-type calcium channels in central and peripheral neurons
Z Lin, Y Lin, S Schorge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2018
Contribution of NIH funding to new drug approvals 2010-2016
Ekaterina Galkina Cleary, Jennifer M Beierlein, Navleen Surjit Khanuja, et al.
Page
of 2